- Hypertension and cardiovascular prevention: where are combinations going?2013 | First Faculty of Medicine
- Polypill Strategy in Secondary Cardiovascular Prevention2022 | First Faculty of Medicine
- Are new antihypertensives more efficient in cardiovascular prevention than diuretics and beta blockers?2003 | Faculty of Medicine in Pilsen
- Fixed combinations in cardiovascular prevention and treatment - present and future2013 | First Faculty of Medicine
- Cardiovascular prevention2006 | First Faculty of Medicine
- Look back at the latest guidelines for cardiovascular prevention2013 | First Faculty of Medicine
- A strategy for cardiovascular prevention: that's what matters!2019 | First Faculty of Medicine
- Cardiovascular prevention in menopause2009 | First Faculty of Medicine
- Questions cardiovascular prevention 20092009 | First Faculty of Medicine
- Cardiovascular prevention in elderly - it is never too late2008 | First Faculty of Medicine
- Pharmaceutical care in cardiovascular prevention2014 | Faculty of Pharmacy in Hradec Králové
- The canging scene of cardiovascular prevention2015 | Faculty of Medicine in Pilsen
- Atherosclerosis, cardiovascular prevention and hormone replacement therapy in menopausal womenPublication without faculty affiliation
- Adherence to cardiovascular prevention principles in subjects at high risk2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Residual risk: a new target of cardiovascular prevention2009 | First Faculty of Medicine
- What should not be done and why - cardiovascular prevention in the light of the latest recommendations2017 | First Faculty of Medicine
- News in cardiovascular prevention: from guidelines to novel treatment options2015 | First Faculty of Medicine
- Pictures of plaques and fixed drug combination for better cardiovascular prevention2018 | Second Faculty of Medicine
- The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension2017 | First Faculty of Medicine
- Importance of fixed-dose combinations in cardiovascular prevention: the possibility of treating two diagnoses with a single pill2019 | First Faculty of Medicine
- The role of a center for tobacco-dependent in cardiovascular prevention. A retrospective study2012 | First Faculty of Medicine
- Blockade of the renin-angiotensin-aldosteron system (RAAS) in secondary cardiovascular prevention2009 | First Faculty of Medicine
- EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries2016 | First Faculty of Medicine
- The changes in cardiovascular prevention practice between 1995-2017 in the Czech Republic: a comparison of EUROASPIRE I, II, III, IV and V study2018 | Faculty of Medicine in Pilsen
- Early and comprehensive cardiovascular prevention in a general practitioner's office. Dyslipidemia and hypertension: The two most common risk factors and the possibility of their EARLY control2020 | Second Faculty of Medicine
- The changes in cardiovascular prevention practice between 1995 and 2012 in the Czech Republic. A comparison of EUROASPIRE I, II, III and IV study2014 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Simvastatin jubilee2013 | First Faculty of Medicine
- Atherosclerosis: from etiology to its possible influencing2015 | First Faculty of Medicine
- Lipid-Lowering Pharmacotherapy in Central and Eastern European Countries in Cardiovascular Prevention: Self-Reported Prescription Patterns of Primary Care Physicians2013 | First Faculty of Medicine
- Evolocumab, proproteine convertase subtilisin/kexin type 9 inhibitor for intensive treatment of dyslipidemia2016 | Faculty of Medicine in Pilsen